HF
VTVT icon

HRT Financial’s vTv Therapeutics VTVT Stock Holding History

HRT Financial’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
+5,923
New +$205K ﹤0.01% 3339
2023
Q1 		– Sell
-420
Closed -$10K – 3263
2022
Q4 		$10K Buy
+420
New +$13.9K ﹤0.01% 2224
2021
Q3 		– Sell
-6,081
Closed -$554K – 3808
2021
Q2 		$554K Buy
+6,081
New +$616K 0.01% 1665

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial's VTVT Position: Q2 2026 in Review

HRT Financial opened a new position in vTv Therapeutics (VTVT) in Q2 2026: 5,923 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #3339 among its holdings. This is a return to the name: HRT Financial previously reported a position in VTVT as recently as Q4 2022.

HRT Financial first reported a position in VTVT in Q2 2021 and has held it in 3 quarters since. The position peaked at $554K in Q2 2021. 45 funds tracked by Wall St. Rank hold VTVT as of Q2 2026.

  • HRT Financial held 5,923 shares of vTv Therapeutics worth $223K as of Q2 2026.
  • vTv Therapeutics was a new HRT Financial position in Q2 2026.
  • vTv Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3339 holding.
  • HRT Financial first reported a position in vTv Therapeutics in Q2 2021 and has held it in 3 quarters since.
  • HRT Financial's vTv Therapeutics position peaked at $554K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held vTv Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.